Table 2.
Parameter | Fistulas |
Grafts |
||||
---|---|---|---|---|---|---|
RR | 95% CI | P | RR | 95% CI | P | |
Quartile of intradialytic hypotensiona | ||||||
Q1 | 1.00 | Reference | – | 1.00 | Reference | – |
Q2 | 1.06 | 0.48 to 2.33 | 0.88 | 1.28 | 0.95 to 1.73 | 0.11 |
Q3 | 1.41 | 0.96 to 2.08 | 0.08 | 1.02 | 0.87 to 1.18 | 0.82 |
Q4 | 2.02 | 1.22 to 3.35 | 0.0063 | 1.11 | 0.92 to 1.34 | 0.27 |
Age (per 10-year increase) | 0.85 | 0.73 to 0.99 | 0.032 | 0.99 | 0.92 to 1.06 | 0.71 |
Female gender (versus male) | 0.74 | 0.49 to 1.12 | 0.15 | 0.93 | 0.77 to 1.12 | 0.43 |
Black race (versus nonblack) | 1.29 | 0.82 to 2.03 | 0.27 | 1.17 | 0.96 to 1.44 | 0.12 |
Current smoker (versus no) | 1.07 | 0.65 to 1.74 | 0.80 | 1.03 | 0.78 to 1.35 | 0.86 |
Past medical history (versus none) | ||||||
diabetes mellitus | 0.98 | 0.61 to 1.56 | 0.93 | 1.13 | 0.94 to 1.35 | 0.20 |
ischemic heart disease | 0.75 | 0.49 to 1.14 | 0.18 | 0.92 | 0.76 to 1.11 | 0.37 |
congestive heart failure | 1.22 | 0.82 to 1.82 | 0.32 | 0.92 | 0.75 to 1.12 | 0.40 |
peripheral vascular disease | 1.51 | 0.93 to 2.46 | 0.094 | 1.14 | 0.93 to 1.39 | 0.20 |
Hospitalized during the assessment period (versus no) | 1.26 | 0.91 to 1.75 | 0.17 | 1.12 | 0.98 to 1.29 | 0.61 |
Predialysis SBP (per 1-SD increase) | 0.92 | 0.74 to 1.15 | 0.45 | 0.88 | 0.80 to 0.97 | 0.0099 |
Serum albumin (per 0.1-g/dl increase) | 0.92 | 0.87 to 0.97 | 0.0037 | 0.96 | 0.93 to 0.98 | 0.0014 |
Hematocrit (per 1% increase) | 0.98 | 0.98 to 1.03 | 0.48 | 1.00 | 0.98 to 1.01 | 0.51 |
Randomization group | ||||||
high versus conventional dose | 0.96 | 0.66 to 1.39 | 0.83 | 1.09 | 0.91 to 1.30 | 0.36 |
high versus low flux | 1.45 | 1.01 to 2.10 | 0.046 | 1.03 | 0.86 to 1.22 | 0.78 |
Analyses adjusted for all variables listed in the table, as well as clinical center. RR, relative rate.
aGlobal P value for fistulas = 0.069; grafts = 0.41.